A study of the effect of gender on interferon beta-1a (Avonex® 30 mcg) treatment in patients with multiple sclerosis

被引：0
作者：
Munschauer, FE
Herndon, R
Sandrock, AW
Tsao, E
Berkhoff, JE
Stubbendick, A
机构：
[1] Jacobs Neurol Inst, Buffalo, NY USA
[2] Univ Mississippi, Jackson, MS 39216 USA
[3] Biogen Idec, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
[41]   Efficacy of doxycycline as add-on to interferon beta-1a in treatment of multiple sclerosis [J].
Mazdeh, Mehrdokht ;
Mobaien, Ahmad Reza .
IRANIAN JOURNAL OF NEUROLOGY, 2012, 11 (02) :70-73
[42]   Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis [J].
Mohr, DC ;
Likosky, W ;
Dwyer, P ;
Van der Wende, J ;
Boudewyn, AC ;
Goodkin, DE .
ARCHIVES OF NEUROLOGY, 1999, 56 (10) :1263-1265
[43]   Interferon-β-1a (Avonex) 30 mcg and 60 mcg are equally effective in patients with relapsing multiple sclerosis:: results from the Cyprus study site of the European IFNβ-1a Dose Comparison Study [J].
Kkolou, E ;
Papacostas, S ;
Kyriallis, K ;
Toufexis, J ;
Pantzaris, M .
MULTIPLE SCLEROSIS, 2004, 10 (7032) :S243-S243
[44]   Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis [J].
Mahe, Julien ;
Meurette, Aurelie ;
Moreau, Anne ;
Vercel, Caroline ;
Jolliet, Pascale .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 :723-728
[45]   Treatment of early onset multiple sclerosis with suboptimal dose of interferon beta-1a [J].
Pakdaman, H. ;
Fallah, A. ;
Sahraian, M. A. ;
Pakdaman, R. ;
Meysamie, A. .
NEUROPEDIATRICS, 2006, 37 (04) :257-260
[46]   Utilization of the multiple sclerosis functional composite as an outcome measure in the phase 3 trial of interferon beta-1a (Avonex®) in secondary progressive multiple sclerosis (IMPACT) [J].
Cohen, JA ;
Cutter, GC ;
Simonian, NA ;
Goodman, AD ;
Heidenreich, FR ;
Simon, JH ;
Whitaker, JN .
NEUROLOGY, 1999, 52 (06) :A548-A549
[47]   EFFECT OF INTERFERON BETA-1A SC ON LESION IRON CONTENT IN MULTIPLE SCLEROSIS [J].
Zivadinov, Robert ;
Markovic-Plese, Silva ;
Dwyer, Michael G. ;
Hayward, Brooke ;
Bergsland, Niels ;
Heininen-Brown, Mari ;
Carl, Ellen ;
Kennedy, Cheryl ;
Dangond, Fernando ;
Weinstock-Guttman, Bianca .
MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (10) :1416-1417
[48]   The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis [J].
Patten, SB ;
Francis, G ;
Metz, LM ;
Lopez-Bresnahan, M ;
Chang, P ;
Curtin, F .
MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (02) :175-181
[49]   Chronic myeloid leukaemia in two multiple sclerosis patients on interferon beta-1a [J].
Almeida, L. ;
Neves, M. ;
Cardoso, E. ;
Melo, A. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2009, 34 (01) :125-127
[50]   Risk of stroke in patients with multiple sclerosis treated with subcutaneous interferon beta-1a [J].
Sabido-Espin, M. ;
Venkatesh, S. ;
Aldridge, J. ;
Gillett, A. .
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 :1022-1022
12345